Kiniksa Pharmaceuticals chief accounting officer Michael R. Megna reports $1.11 million common share sale
KNSA•Chief Accounting Officer Michael R. Megna sold 11,280 Kiniksa Pharmaceuticals Class A ordinary shares at $98.54 each on Nov. 9, 2026, and exercised options for the same number of shares at $17.76 each.
1. Share transactions
Megna sold 11,280 Class A ordinary shares at $98.54 each and exercised options for 11,280 shares at $17.76 each on Nov. 9, 2026. After the transactions, he directly owned 12,697 Class A ordinary shares and held 5,114 share options.
